Neither P16 gene status nor p16INK4a protein expression alone is an independent predictor of urothelial bladder carcinoma, but combine gene and protein status together providing useful information on the clinical outcome of these patients. The gene discussed is CDKN2A; the disease is bladder transitional cell carcinoma.